advertising
-
1
Schurer A, Manley G, Wach W: “International Patient Survey (Part 2: Ledderhose Disease),” in Dupuytren Disease and Related Diseases: The Cutting Edge, edited by P Werker, J Dias, C Eaton, et al., p 371, Springer International Publishing, Cham, Switzerland, 2017.
-
2
Rödel F, Fournier C, Wiedermann J, et al.: Basics of radiation biology when treating hyperproliferative benign diseases. Front Immunol 8: 1, 2017.
-
3
Heyd R, Dorn AP, Herkströter M, et al.: Radiation therapy for early stages of morbus Ledderhose. Strahlenther Onkol 186: 24, 2010.
-
4
Seegenschmiedt MH, Wielpütz M, Hanslian E, et al.: “Long-Term Outcome of Radiotherapy for Primary and Recurrent Ledderhose Disease,” in Dupuytren’s Disease and Related Hyperproliferative Disorders, edited by C Eaton, M Seegenschmiedt, A Bayat, et al., p 409, Springer, Berlin, Heidelberg, 2012.
-
5
Grenfell S, Borg M: Radiotherapy in fascial fibromatosis: a case series, literature review and considerations for treatment of early-stage disease. J Med Imaging Radiat Oncol 58: 641, 2014.
-
6
Seegenschmiedt MH: “Morbus Dupuytren/Morbus Ledderhose,” in Radiotherapy or Non-Malignant Disorders, edited by MH Seegenschmiedt, HB Makoski, KR Trott, et al., p 161, Springer, Berlin, Heidelberg, 2008.
-
7
Banks JS, Wolfson AH, Subhawong TK: T2 signal intensity as an imaging biomarker for patients with superficial fibromatoses of the hands (Dupuytren’s disease) and feet (Ledderhose disease) undergoing definitive electron beam irradiation. Skeletal Radiol 47: 243, 2017.
-
8
Bree ED, Zoetmulder FA, Keus RB, et al.: Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy. Am J Surg 187: 33, 2002.
-
9
Young JR, Sternbach S, Willinger M, et al.: The etiology, evaluation, and management of plantar fibromatosis. Orthop Res Rev 11: 1, 2018.
-
10
Seegenschmiedt MH, Keilholz L, Wielpütz M, et al.: “Long-Term Outcome of Radiotherapy for Early Stage Dupuytren’s Disease: A Phase III Clinical Study,” in Dupuytren’s Disease and Related Hyperproliferative Disorders, Eaton C, Seegenschmiedt M, Bayat A, et al., eds, p 349, Springer, Berlin, Heidelberg, 2012.
-
11
Betz N, Ott OJ, Adamietz B, et al.: Radiotherapy in early-stage Dupuytren’s contracture: long-term results after 13 years. Strahlenther Onkol 186: 82, 2010.
-
12
Brewster A: “The Use of Radiotherapy in the Treatment of Benign Conditions,” in Practical Clinical Oncology, p 449, Cambridge University Press, Cambridge, England, 2008; DOI: https://doi.org/10.1017/CBO9780511545375.040.
Radiotherapy for Plantar Fibromas (Ledderhose Disease)
Search for other papers by John D. Mozena in
Current site
Google Scholar
PubMed
Search for other papers by Eric K. Hansen in
Current site
Google Scholar
PubMed
Search for other papers by Paul Clint Jones in
Current site
Google Scholar
PubMed
Ledderhose disease (plantar fibromas) is histologically related to Dupuytren disease, which has been successfully treated for years with radiotherapy. Many conservative treatments have been advanced for plantar fibromas, including accommodative orthotic devices, which help but do not cure the disease. Surgery is considered the mainstay of treatment for this malady, but the failure rate has been as high as 100%, depending on the type of fasciectomy. Radiotherapy is a new, exciting modality that has shown promising results for treating plantar fibromas.
advertising
